194 related articles for article (PubMed ID: 2550147)
21. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Kuraya M; Yefenof E; Klein G; Klein E
Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
[TBL] [Abstract][Full Text] [Related]
22. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
[TBL] [Abstract][Full Text] [Related]
23. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
[TBL] [Abstract][Full Text] [Related]
24. Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity.
Mitrani-Rosenbaum S; Ber R; Goldblum N; Povey S; Gamliel H; Ben-Bassat H
Int J Cancer; 1982 Nov; 30(5):593-600. PubMed ID: 6295967
[TBL] [Abstract][Full Text] [Related]
25. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus (EBV) hypersensitivity of peripheral B lymphocytes in patients with EBV genome-positive Burkitt's lymphoma.
Okano M; Mizuno F; Osato T
J Infect; 1995 Jul; 31(1):15-9. PubMed ID: 8522826
[TBL] [Abstract][Full Text] [Related]
27. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
Pearson GR; Orr TW
J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
[TBL] [Abstract][Full Text] [Related]
28. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus.
Traul KA; Stephens R; Gerber P; Peterson WD
Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026
[TBL] [Abstract][Full Text] [Related]
29. Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.
Ramos OF; Sármay G; Klein E; Yefenof E; Gergely J
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5470-4. PubMed ID: 3895232
[TBL] [Abstract][Full Text] [Related]
30. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies.
Sternås L; Luka J; Kallin B; Rosén A; Henle W; Henle G; Klein G
J Immunol Methods; 1983 Oct; 63(2):171-85. PubMed ID: 6311908
[TBL] [Abstract][Full Text] [Related]
31. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
32. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
Reedman BM; Hilgers J; Hilgers F; Klein G
Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
[TBL] [Abstract][Full Text] [Related]
33. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
[TBL] [Abstract][Full Text] [Related]
34. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
Sairenji T; Hinuma Y
Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
[TBL] [Abstract][Full Text] [Related]
35. T lymphocyte-mediated cytotoxicity against autologous EBV-genome-bearing B cells.
Tsoukas CD; Fox RI; Slovin SF; Carson DA; Pellegrino M; Fong S; Pasquali JL; Ferrone S; Kung P; Vaughan JH
J Immunol; 1981 May; 126(5):1742-6. PubMed ID: 6163816
[TBL] [Abstract][Full Text] [Related]
36. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
Boguszaková L; Hirsch I; Brichácek B; Vonka V
J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
[TBL] [Abstract][Full Text] [Related]
37. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
Mori T; Sairenji T
Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
[TBL] [Abstract][Full Text] [Related]
38. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
[TBL] [Abstract][Full Text] [Related]
39. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
40. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
